Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL
Clinical trial NCT02787239 · COMPLETED
Trial details
- NCT number
- NCT02787239
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-05-01
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.